HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Recruiting · NCT04131413 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia | Cervical Intraepithelial Neoplasia, Grade III, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, neoplasm, precancerous condition, uterine disorder | Recruiting | Phase 1 | 2026-07-02 | NCT04131413 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 13 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |